Published in Respir Med on June 01, 2001
Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes (2004) 4.24
Impaired sleep reduces quality of life in chronic obstructive pulmonary disease. Lung (2009) 1.88
Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008. COPD (2013) 1.64
The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med (2012) 1.61
Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis (2014) 1.23
Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis (2015) 1.03
A simplified score to quantify comorbidity in COPD. PLoS One (2014) 0.89
Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD. BMC Pulm Med (2014) 0.87
The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings. BMC Cardiovasc Disord (2010) 0.87
Internet access and use by COPD patients in the National Emphysema/COPD Association Survey. BMC Pulm Med (2014) 0.84
Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review. PLoS One (2015) 0.83
Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med (2016) 0.76
Therapies for insomnia and comorbid chronic obstructive pulmonary disease with a focus on ramelteon (rozerem). P T (2009) 0.75
Methodologic issues in effectiveness research on palliative cancer care: a systematic review. J Clin Oncol (1997) 2.23
Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax (2002) 2.09
Poor biologic activity of cross-reactive IgE directed to carbohydrate determinants of glycoproteins. J Allergy Clin Immunol (1997) 1.76
An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun (1999) 1.75
Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax (2003) 1.70
[Should a patient with a stroke be admitted?]. Ned Tijdschr Geneeskd (1992) 1.64
The prevalence of parasite infestation and house dust mite sensitization in Gabonese schoolchildren. Int Arch Allergy Immunol (2001) 1.47
IgG4 antibodies against rodents in laboratory animal workers do not protect against allergic sensitization. Allergy (2010) 1.46
Relation between IgG antibodies to foods and IgE antibodies to milk, egg, cat, dog and/or mite in a cross-sectional study. Clin Exp Allergy (1999) 1.42
Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol (1986) 1.37
Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. J Immunol (1986) 1.33
Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol (2001) 1.30
Serum surfactant protein D is elevated in allergic patients. Clin Exp Allergy (2004) 1.20
Reduced production of IL-12 and IL-12-dependent IFN-gamma release in patients with allergic asthma. J Immunol (1997) 1.20
Management of spontaneous miscarriage in the first trimester: an example of putting informed shared decision making into practice. BMJ (2001) 1.12
Atopy, lung function, and obstructive airways disease after prenatal exposure to famine. Thorax (2000) 1.11
Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J (2004) 1.08
Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism. Genes Immun (2002) 1.07
Der p 1 and Der p 2 induce less severe late asthmatic responses than native Dermatophagoides pteronyssinus extract after a similar early asthmatic response. Clin Exp Allergy (2001) 1.04
Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin. Eur Respir J (2006) 1.04
Pneumoconiosis and emphysema in construction workers: results of HRCT and lung function findings. Occup Environ Med (2011) 0.98
Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics. Allergy (2010) 0.92
Influx of neutrophils into the airway lumen at 4 h after segmental allergen challenge in asthma. Int Arch Allergy Immunol (1999) 0.92
The stripped basophil histamine release bioassay as a tool for the detection of allergen-specific IgE in serum. Int Arch Allergy Immunol (2001) 0.91
The impact of drug users on inpatient hospital care during the human immunodeficiency virus epidemic in Amsterdam. Int J Epidemiol (1996) 0.90
False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergens. J Allergy Clin Immunol (1996) 0.87
Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma. J Lab Clin Med (2000) 0.86
Identification of a cross-reactive allergen (presumably tropomyosin) in shrimp, mite and insects. Int Arch Allergy Immunol (1994) 0.86
Lipopolysaccharide amplifies eosinophilic inflammation after segmental challenge with house dust mite in asthmatics. Allergy (2014) 0.85
Double staining of intracellular cytokine proteins and T-lymphocyte subsets. Evaluation of the method in blood and bronchoalveolar lavage fluid. Histochem J (2000) 0.85
Biphasic effect-time courses in man after formoterol inhalation: eosinopenic and hypokalemic effects and inhibition of allergic skin reactions. J Pharmacol Exp Ther (1997) 0.85
The relationship between RAST and skin test results in patients with asthma or rhinitis: a quantitative study with purified major allergens. J Allergy Clin Immunol (1996) 0.84
Similar levels of nitric oxide in exhaled air in non-asthmatic rhinitis and asthma after bronchial allergen challenge. Allergy (2003) 0.82
Fel d 1-specific IgG antibodies induced by natural exposure have blocking activity in skin tests. Int Arch Allergy Immunol (1996) 0.82
Immunocytochemical and flow cytofluorimetric detection of intracellular IL-4, IL-5 and IFN-gamma: applications using blood- and airway-derived cells. J Immunol Methods (1997) 0.82
A double-blind study on the effect of inhaled corticosteroids on plasma protein exudation in asthma. Am J Respir Crit Care Med (1999) 0.82
Variability of IgE-dependent histamine-releasing activity in supernatants of human mononuclear cells. Int Arch Allergy Immunol (1994) 0.81
IgE antibodies reactive with silverfish, cockroach and chironomid are frequently found in mite-positive allergic patients. Int Arch Allergy Immunol (1995) 0.81
Allergen-induced bronchial inflammation in house dust mite-allergic patients with or without asthma. Clin Exp Allergy (2002) 0.81
Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma. Thorax (2006) 0.80
Determinants of penicillinase producing Neisseria gonorrhoeae infections in heterosexuals in Amsterdam. Genitourin Med (1994) 0.80
Bronchial allergen challenge in subjects with low levels of allergic sensitization to indoor allergens. Allergy (1999) 0.79
Increase in allergen-specific IgE and ex vivo Th2 responses after a single bronchial challenge with house dust mite in allergic asthmatics. Allergy (2011) 0.79
Trials in palliative care. BMJ (1995) 0.78
[Chronic use of stomach acid inhibitor medication in family practice in the region of Amsterdam]. Ned Tijdschr Geneeskd (1999) 0.78
Reactivity to IgE-dependent histamine-releasing factor is due to monomeric IgE. Allergy (2000) 0.78
Asthmatic airways obstruction assessment based on detailed analysis of respiratory sound spectra. IEEE Trans Biomed Eng (2000) 0.78
Short-term predictions of HIV prevalence and AIDS incidence. Epidemiol Infect (1992) 0.77
Bronchial allergen challenge with isolated major allergens of Dermatophagoides pteronyssinus: the role of patient characteristics in the early asthmatic response. J Allergy Clin Immunol (1998) 0.77
Quality assessment in general practice trainers. Med Educ (2000) 0.77
Human proteins in house dust. Allergy (1993) 0.76
Anti-IgE and other new immunomodulation-based therapies for allergic asthma. Neth J Med (2005) 0.76
Reactivity to IgE-dependent histamine-releasing activity in asthma or rhinitis. Am J Respir Crit Care Med (1996) 0.76
The late asthmatic response is associated with baseline allergen-specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin-5. Clin Exp Allergy (1999) 0.75
[The acute stage of cerebrovascular accident (CVA); characteristics and management]. Ned Tijdschr Geneeskd (1992) 0.75
Early detection of breast cancer: compromise guidelines for a primary care setting. J Cancer Educ (1989) 0.75
Segmental allergen challenge induces plasma protein leakage into the airways of asthmatic subjects at 4 hours but not at 5 minutes after challenge. J Lab Clin Med (1999) 0.75
Inadvertent BSA-induced elution of IgE in the BSA-RAST. Allergy (2001) 0.75
Basophils from patients with allergic asthma show a primed phenotype. J Allergy Clin Immunol (1999) 0.75
[Patients without referral treated in the emergency room: patient characteristics and motives]. Ned Tijdschr Geneeskd (2000) 0.75
[Traumatic duodenal perforation due to the safety belt syndrome]. Ned Tijdschr Geneeskd (1977) 0.75
[The quality of statistics on causes of death as recorded by the family physician]. Ned Tijdschr Geneeskd (1986) 0.75
[Children with HIV/AIDS; initial experiences with school placement]. Ned Tijdschr Geneeskd (1995) 0.75
Differences in nonspecific bronchial responsiveness between patients with asthma and patients with rhinitis are not explained by type and degree of inhalant allergy. Int Arch Allergy Immunol (1997) 0.75
[Estimate of the number of HIV-infected intravenous drug users in Amsterdam]. Ned Tijdschr Geneeskd (1992) 0.75
Estimating the size of the HIV epidemic among injecting drug users in Amsterdam. Eur J Epidemiol (1997) 0.75
[Intra- and extramural workshop for care, teaching, and research]. Ned Tijdschr Geneeskd (1997) 0.75
Positive attitude towards antiretroviral therapy after 6 months of treatment in a sample of Dutch HIV infected people. Sex Transm Infect (1999) 0.75
[Health care on Saba as reflected in mortality statistics]. Ned Tijdschr Geneeskd (1987) 0.75
Late presentation of HIV infected patients at Amsterdam outpatient HIV clinics. Sex Transm Infect (1999) 0.75
[Pollinosis as a cause of allergy to vegetables]. Ned Tijdschr Geneeskd (1986) 0.75
Role of the general practitioner in breast cancer screening in The Netherlands. J Cancer Educ (1991) 0.75
Aerosol recovery from large-volume reservoir delivery systems is highly dependent on the static properties of the reservoir. Eur Respir J (1999) 0.75
[A different form for the certification of cause of death]. Ned Tijdschr Geneeskd (1986) 0.75
Dynamics in cytokine responses during the development of occupational sensitization to rats. Allergy (2010) 0.75
[Social and normative aspects of medical technology]. Ned Tijdschr Geneeskd (1995) 0.75
[Severe bronchial asthma]. Ned Tijdschr Geneeskd (2013) 0.75
Changing attitudes towards antiretroviral treatment of HIV infection: a prospective study in a sample of Dutch general practitioners. AIDS Care (1999) 0.75
Human IgM antibodies do not activate guinea-pig complement after interaction with soluble antigen. Mol Immunol (1986) 0.75
[AIDS epidemic in The Netherlands: current developments in transmission route, age and nationality]. Ned Tijdschr Geneeskd (1997) 0.75
[Need for and financing of 'workplaces' outside academic and affiliated hospitals in medical education]. Ned Tijdschr Geneeskd (1995) 0.75
[Causes of death in patients in general practice; organization of a reviewing system]. Ned Tijdschr Geneeskd (1981) 0.75
Evaluation of an expanded two-ELISA approach for confirmation of reactive serum samples in an HIV-screening programme for pregnant women. J Med Virol (1998) 0.75